 | • レポートコード：MRC23Q36095 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の不活化ポリオワクチン市場について調査・分析し、世界の不活化ポリオワクチン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（タイプⅠ、タイプⅡ、タイプⅢ）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCAなどが含まれています。世界の不活化ポリオワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、不活化ポリオワクチン市場規模を推定する際に考慮しました。本レポートは、不活化ポリオワクチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、不活化ポリオワクチンに関するビジネス上の意思決定に役立てることを目的としています。 ・不活化ポリオワクチン市場の概要 - 不活化ポリオワクチンのタイプ別セグメント - 世界の不活化ポリオワクチン市場規模：タイプ別分析（タイプⅠ、タイプⅡ、タイプⅢ） - 不活化ポリオワクチンの用途別セグメント - 世界の不活化ポリオワクチン市場規模：用途別分析（病院、診療所） - 世界の不活化ポリオワクチン市場規模予測（2018年-2029年） ・不活化ポリオワクチン市場の成長トレンド - 不活化ポリオワクチンの地域別市場規模（2018年-2029年） - 不活化ポリオワクチン市場ダイナミクス - 不活化ポリオワクチンの業界動向 - 不活化ポリオワクチン市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：タイプⅠ、タイプⅡ、タイプⅢ - 世界の不活化ポリオワクチンのタイプ別市場規模（2018年-2023年） - 世界の不活化ポリオワクチンのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所 - 世界の不活化ポリオワクチンの用途別市場規模（2018年-2023年） - 世界の不活化ポリオワクチンの用途別市場規模（2024年-2029年） ・不活化ポリオワクチンの地域別市場規模 - 北米の不活化ポリオワクチン市場規模（2018年-2029年） - アメリカの不活化ポリオワクチン市場規模（2018年-2029年） - ヨーロッパの不活化ポリオワクチン市場規模（2018年-2029年） - アジア太平洋の不活化ポリオワクチン市場規模（2018年-2029年） - 中国の不活化ポリオワクチン市場規模（2018年-2029年） - 日本の不活化ポリオワクチン市場規模（2018年-2029年） - 韓国の不活化ポリオワクチン市場規模（2018年-2029年） - インドの不活化ポリオワクチン市場規模（2018年-2029年） - オーストラリアの不活化ポリオワクチン市場規模（2018年-2029年） - 中南米の不活化ポリオワクチン市場規模（2018年-2029年） - 中東・アフリカの不活化ポリオワクチン市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCA ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Inactivated Polio Virus Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Inactivated Polio Virus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Inactivated Polio Virus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Inactivated Polio Virus Vaccine in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Inactivated Polio Virus Vaccine include Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Polio Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Polio Virus Vaccine.
The Inactivated Polio Virus Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inactivated Polio Virus Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Polio Virus Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Type I
Type II
Type III
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Polio Virus Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Market by Application
1.3.1 Global Inactivated Polio Virus Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Polio Virus Vaccine Market Perspective (2018-2029)
2.2 Inactivated Polio Virus Vaccine Growth Trends by Region
2.2.1 Global Inactivated Polio Virus Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Inactivated Polio Virus Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Inactivated Polio Virus Vaccine Market Dynamics
2.3.1 Inactivated Polio Virus Vaccine Industry Trends
2.3.2 Inactivated Polio Virus Vaccine Market Drivers
2.3.3 Inactivated Polio Virus Vaccine Market Challenges
2.3.4 Inactivated Polio Virus Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue
3.1.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue (2018-2023)
3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inactivated Polio Virus Vaccine Revenue
3.4 Global Inactivated Polio Virus Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Polio Virus Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Polio Virus Vaccine Revenue in 2022
3.5 Inactivated Polio Virus Vaccine Key Players Head office and Area Served
3.6 Key Players Inactivated Polio Virus Vaccine Product Solution and Service
3.7 Date of Enter into Inactivated Polio Virus Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Polio Virus Vaccine Breakdown Data by Type
4.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2024-2029)
5 Inactivated Polio Virus Vaccine Breakdown Data by Application
5.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Inactivated Polio Virus Vaccine Market Size (2018-2029)
6.2 North America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
6.4 North America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inactivated Polio Virus Vaccine Market Size (2018-2029)
7.2 Europe Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
7.4 Europe Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inactivated Polio Virus Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Inactivated Polio Virus Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2018-2023)
8.4 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inactivated Polio Virus Vaccine Market Size (2018-2029)
9.2 Latin America Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
9.4 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inactivated Polio Virus Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
10.4 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Inactivated Polio Virus Vaccine Introduction
11.1.4 Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Inactivated Polio Virus Vaccine Introduction
11.2.4 GSK Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Serum Institute (Bilthoven Biologicals)
11.3.1 Serum Institute (Bilthoven Biologicals) Company Detail
11.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Introduction
11.3.4 Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.3.5 Serum Institute (Bilthoven Biologicals) Recent Development
11.4 IMBCA
11.4.1 IMBCA Company Detail
11.4.2 IMBCA Business Overview
11.4.3 IMBCA Inactivated Polio Virus Vaccine Introduction
11.4.4 IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2018-2023)
11.4.5 IMBCA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details